Medicare Enrolled
Dr. Ananth Arjunan, MD
Hematology & Oncology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Arjunan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arjunan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arjunan
Dr. Ananth Arjunan is a hematology & oncology specialist in Dallas, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Arjunan performed 53,402 Medicare services across 1,602 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arjunan received a total of $15,194 from 75 pharmaceutical and/or device companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arjunan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 18% volume in TX
$15,194 industry payments
Medicare Practice Summary
Medicare Utilization ↗53,402
Medicare services
Top 18% in TX for hematology & oncology
1,602
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,814 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 20,200 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 11,755 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 8,200 | $43 | $136 |
| Anti-nausea injection (fosaprepitant) | 5,250 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 2,400 | $0 | $3 |
| Dexamethasone injection (steroid) | 930 | $0 | $1 |
| Complete blood count (CBC) with differential | 595 | $8 | $36 |
| Blood draw (venipuncture) | 564 | $8 | $20 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 440 | $0 | $24 |
| Injection, fluorouracil, 500 mg | 373 | $2 | $13 |
| Office visit, established patient (30-39 min) | 307 | $93 | $368 |
| Office visit, established patient (20-29 min) | 223 | $63 | $250 |
| Drug injection, under skin or into muscle | 201 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 167 | $49 | $313 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 161 | $23 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 141 | $99 | $707 |
| Comprehensive metabolic blood panel | 123 | $10 | $64 |
| Injection, zoledronic acid, 1 mg | 117 | $7 | $431 |
| Injection of additional new drug or substance into vein | 71 | $12 | $108 |
| Hospital follow-up visit, high complexity | 53 | $94 | $357 |
| Administration of chemotherapy into vein, each additional hour | 50 | $22 | $161 |
| Office visit, established patient, complex (40-54 min) | 49 | $125 | $496 |
| Injection, diphenhydramine hcl, up to 50 mg | 47 | $1 | $7 |
| Irrigation of implanted venous access drug delivery device | 42 | $20 | $114 |
| Ferritin level test (iron stores) | 40 | $13 | $60 |
| Iron level test | 40 | $6 | $27 |
| Iron binding capacity test | 40 | $9 | $35 |
| Microscopic examination for white blood cells with manual cell count | 40 | $4 | $22 |
| Complete blood count (CBC), automated | 40 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 40 | $15 | $100 |
| Initial hospital admission, high complexity | 37 | $136 | $694 |
| Administration of additional new drug or substance into vein, 1 hour or less | 35 | $50 | $344 |
| New patient office visit, complex (60-74 min) | 35 | $163 | $709 |
| Measurement of immunoglobulin light chains | 30 | $17 | $60 |
| Ct scan of chest with contrast | 24 | $49 | $821 |
| Reticulated (young) platelet measurement | 23 | $35 | $143 |
| CT scan of abdomen and pelvis with contrast | 20 | $186 | $1,067 |
| Blood creatinine level | 16 | $5 | $31 |
| Lactate dehydrogenase (enzyme) level | 13 | $6 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
94.9% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,194
Total received (2018-2024)
Avg $2,171/year across 7 years
Top 25% in TX for hematology & oncology
75
Companies
421
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,916 (65.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,093 (20.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,185 (14.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,693
2023
$3,981
2022
$1,384
2021
$1,575
2020
$1,606
2019
$1,608
2018
$347
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$3,138
Janssen Scientific Affairs, LLC
$1,818
AstraZeneca Pharmaceuticals LP
$1,075
E.R. Squibb & Sons, L.L.C.
$707
Janssen Biotech, Inc.
$663
BeiGene, Ltd.
$525
Rigel Pharmaceuticals, Inc.
$383
Medtronic, Inc.
$363
Amgen Inc.
$350
Athenex Pharmaceutical Division, LLC
$350
Lilly USA, LLC
$308
Merck Sharp & Dohme LLC
$308
Novartis Pharmaceuticals Corporation
$306
Regeneron Healthcare Solutions, Inc.
$263
Gilead Sciences, Inc.
$239
Takeda Pharmaceuticals U.S.A., Inc.
$236
Merck Sharp & Dohme Corporation
$223
GENZYME CORPORATION
$211
Bayer Healthcare Pharmaceuticals Inc.
$209
Novocure GmbH
$200
PharmaEssentia USA Corporation
$199
Astellas Pharma US Inc
$171
Sirtex Medical Inc
$153
Clovis Oncology, Inc.
$136
GlaxoSmithKline, LLC.
$131
Eisai Inc.
$129
ARRAY BIOPHARMA INC
$123
Kite Pharma, Inc.
$119
Tempus AI, Inc
$111
Incyte Corporation
$110
Daiichi Sankyo Inc.
$103
Helsinn Therapeutics (U.S.), Inc.
$96
SOBI, INC
$86
Genentech USA, Inc.
$85
EMD Serono, Inc.
$83
TerSera Therapeutics LLC
$83
Celgene Corporation
$79
Pharmacyclics LLC, An AbbVie Company
$74
Blueprint Medicines Corporation
$70
Karyopharm Therapeutics Inc.
$69
Ipsen Biopharmaceuticals, Inc
$65
JAZZ PHARMACEUTICALS INC.
$64
Seagen Inc.
$60
Agios Pharmaceuticals, Inc.
$51
SERVIER PHARMACEUTICALS LLC
$48
Mirati Therapeutics, Inc.
$47
ABBVIE INC.
$43
Secura Bio, Inc.
$41
Dova Pharmaceuticals
$40
PUMA BIOTECHNOLOGY, INC.
$39
Alexion Pharmaceuticals, Inc.
$37
TESARO, Inc.
$37
Sun Pharmaceutical Industries Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
Seattle Genetics, Inc.
$34
Deciphera Pharmaceuticals Inc.
$32
Verastem, Inc.
$31
Emmaus Medical, Inc.
$29
BeiGene USA, Inc.
$29
Adaptive Biotechnologies Corporation
$29
Immunomedics, Inc.
$28
Genmab U.S., Inc.
$27
Heron Therapeutics, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Stemline Therapeutics Inc.
$19
AbbVie Inc.
$19
Puma Biotechnology, Inc.
$18
MorphoSys, US Inc.
$18
Legend Biotech USA Inc.
$17
EISAI INC.
$17
Alnylam Pharmaceuticals Inc.
$16
Kyowa Kirin, Inc.
$16
Acrotech Biopharma Inc.
$15
ADC Therapeutics America, Inc.
$14
Taiho Oncology, Inc.
$12
Top 3 companies account for 39.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Aliqopa · BALVERSA · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · BYNFEZIA PEN · Bavencio · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · COPIKTRA · CYRAMZA · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Endari · Enhertu · FRUZAQLA · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · Orserdu · PADCEV · PLUVICTO · PROMACTA · PYRUKYND · Padcev · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TECVAYLI · TRUSELTIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Vanflyta · Venclexta · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · XYNTHA · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $28 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
114
Per 100K population
4.4
County median income
$74,149
Nearest hospital
METHODIST CHARLTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Arjunan is a mixed practice specialist, with above-average Medicare volume (top 18% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Arjunan experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Arjunan performed 20,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arjunan receive payments from pharmaceutical companies?
Yes. Dr. Arjunan received a total of $15,194 from 75 companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arjunan's costs compare to other hematology & oncology specialists in Dallas?
Dr. Arjunan's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arjunan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Dallas
Browse hematology & oncology specialists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology